Jeffrey Landau
Corporate Officer/Principal at CYTOMX THERAPEUTICS, INC.
Net worth: 200 158 $ as of 2024-05-30
Profile
Jeffrey Landau's career history includes current and former positions as well as his education background.
Currently, he is the Chief Business Officer, Senior VP & Head-Strategy at CytomX Therapeutics, Inc. Prior to his current role, he held the position of Vice President-Business Development at Catalyst Biosciences, Inc. from 2016 to 2021.
Before that, he worked as the Director-Corporate Development & Marketing at Threshold Pharmaceuticals, Inc. Mr. Landau completed his undergraduate degree at Virginia Polytechnic Institute & State University and holds an MBA from Stanford Graduate School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-18 | 117,740 ( 0.15% ) | 200 158 $ | 2024-05-30 |
Jeffrey Landau active positions
| Companies | Position | Start |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Corporate Officer/Principal | 2021-03-31 |
Former positions of Jeffrey Landau
| Companies | Position | End |
|---|---|---|
| CATALYST BIOSCIENCES | Corporate Officer/Principal | 2021-02-28 |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Sales & Marketing | - |
Training of Jeffrey Landau
| Virginia Polytechnic Institute & State University | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Health Technology |
- Stock Market
- Insiders
- Jeffrey Landau
